Viking aims to compete against market giants Eli Lilly and Novo Nordisk in the billion-dollar weight loss drug market. The ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO), the kings of the titanic weight-loss drugs market, might have a problem ...

The latest celebrity weight-loss drug to be given the nod in Hong Kong will be available in December, but experts cautioned ...

Eli Lilly's weight loss drug sales in Q3 weren't as strong as it anticipated ... The Motley Fool recommends Novo Nordisk. The ...

The oral form has completed a phase 1 study, and Novo Nordisk reported results from the first 16 patients out of a total planned enrolment of 144. After 12 weeks, weight loss with the drug was 13% ...

In Clayton, N.C., pharmaceutical giant Novo Nordisk has announced a $4.1 billion investment to increase production of the ...

In corporate news, Novo Nordisk A/S (NOVOB.C.DX) surged over +7% after the pharmaceutical giant reported better-than-expected Q3 sales of its popular Wegovy weight-loss drug and narrowed its full-year ...

Novo Nordisk is paying $55 million upfront to secure rights to a cell therapy for heart failure developed by Japanese startup Heartseed. The Danish drugmaker has acquired exclusive rights outside ...

Watch on DVD or Blu-ray starting July 1st, 2003 - Buy How to Lose a Guy in 10 Days DVD ...

An Afghan delegation will attend the upcoming UN climate change summit in Azerbaijan, the foreign ministry spokesman told AFP on Saturday, marking a first since the Taliban government came to power.